Abstract:Owing to the central role of apoptosis in many human diseases and the widespread application of apoptosis-based therapeutics, molecular imaging of apoptosis in clinical practice is of great interest for clinicians, and holds great promises.Based on the well-defined biochemical changes for apoptosis, a rich assortment of probes and approaches have been developed for molecular imaging of apoptosis with various imaging modalities.Among these imaging techniques, nuclear imaging (including single photon emission computed tomography and positron emission tomography) remains the premier clinical method owing to their high specificity and sensitivity.Therefore, the corresponding radiopharmaceuticals have been a major focus, and some of them like 99m Tc-Annexin V, 18 F-ML-10, 18 F-CP18, and 18 F-ICMT-11 are currently under clinical investigations in Phase I/II or Phase II/III clinical trials on a wide scope of diseases.In this review, we summarize these radiopharmaceuticals that have been widely used in clinical trials and elaborate them in terms of radiosynthesis, pharmacokinetics and dosimetry, and their applications in different clinical stages.We also explore the unique features required to qualify a desirable radiopharmaceutical for imaging apoptosis in clinical practice.Particularly, a perspective of the impact of these clinical efforts, namely, apoptosis imaging as predictive and prognostic markers, early-response indicators and surrogate endpoints, is also the highlight of this review.

Development of small molecular probes for the molecular imaging of apoptosis.

Molecular Imaging of Apoptosis: from Micro to Macro.

Design of "smart" Probes for Optical Imaging of Apoptosis

Real-time Monitoring of Cell Apoptosis and Drug Screening Using Fluorescent Light-Up Probe with Aggregation-Induced Emission Characteristics.

Two-Photon Enzymatic Probes Visualizing Sub-cellular/Deep-brain Caspase Activities in Neurodegenerative Models

Review Article Design of "smart" Probes for Optical Imaging of Apoptosis

Radionuclide imaging of apoptosis for clinical application

Progress on molecular imaging for apoptosis

SPECT and PET Radiopharmaceuticals for Molecular Imaging of Apoptosis: from Bench to Clinic

Design, Synthesis, and Biological Evaluation of 4-(5-dimethylamino-naphthalene-1-sulfon-amido)-3-(4-iodophenyl)butanoic Acid As a Novel Molecular Probe for Apoptosis Imaging

Recent advances in apoptosis imaging using radionuclide-labeled tracers

Tracking Cell Apoptosis Based on Mitochondria and Cell Membrane Imaging

Advances in Small-Molecule Fluorescent Probes for the Study of Apoptosis

Tiny nuance leads to large difference: Construction of fluorescent probes to visualize early and late apoptotic stages

Research Progress of Radionuclide Imaging Probes in Apoptosis

Molecular imaging of cell death in vivo by a novel small molecule probe

Structure-inherent Near-Infrared Fluorescent Probe Mediates Apoptosis Imaging and Targeted Drug Delivery in Vivo

Progress in Imaging Agents of Cell Apoptosis

Multi-armed tetrahedral DNA probes for visualizing the whole-course of cell apoptosis by simultaneously fluorescence imaging intracellular cytochrome c and telomerase

Regulator-carrying dual-responsive integrated AuNP composite fluorescence probe for in situ real time monitoring apoptosis progression